跳至主要内容
临床试验/NCT06489535
NCT06489535已完成不适用

Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN): A Pilot Randomized Controlled Study

Boston Medical Center1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年1月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Participant recruitment rates

研究概览

简要总结

This project is a pilot study of an adapted intervention of an existing Opioid Use Disorder (OUD) treatment retention intervention called Recovery Management Checkups (RMC). This intervention has been adapted to better fit the experiences and unique issues of those that have been hospitalized with serious injection related infections (SIRI) based on the findings from a prior qualitative study from the principal investigator. This project plans to test the adapted intervention within a smaller group of participants to assess feasibility, acceptability, and calculate early findings of intervention efficacy.

Hospitalizations for SIRIs are a unique entry point for patients to start their recovery journey with medications for OUD (MOUD), but many people do not remain on long-term treatment, despite evidence that indicates MOUDs reduce death and re-hospitalization after SIRIs.

The study objectives are to:

  • Assess the implementation feasibility of the adapted RMC model for patients with SIRI and OUD.
  • Establish preliminary estimates of intervention efficacy.
  • Make further adaptions to the intervention that will reduce both known and unknown barriers to care and increase effectiveness in future larger scale trials.

Findings from this pilot study will result in further intervention refinement to better fit the target population, and serve as the basis for a larger randomized control trial that will have aims focused on more in-depth analysis of the efficacy of this program

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Between 18 and 65 years of age
  • Able to provide Informed Consent
  • Admitted to Boston Medical Center on any inpatient unit for an active serious injection related infection (SIRI) such as endocarditis, osteomyelitis, bacteremia, septic arthritis, epidural abscess or other serious infection in which two weeks or more of antibiotics are recommended

排除标准

  • Not able to give informed consent
  • Cognitive ability (defined through Research Assistant (RA) determination)
  • Inability to complete assessments in English or Spanish (defined through RA determination).
  • Exclusion for any reason under PI discretion
  • Unable to provide names and contact information for at least two verifiable locator persons who will know where to find them in the future.
  • In police custody or expecting incarceration

研究组 & 干预措施

RETAIN intervention

Experimental

Participants randomized to the RETAIN intervention will receive Motivational Interviewing targeted to their clinical concerns and personalized support tailored to each participants' specific needs determined by their answers to intake questions.

干预措施: RETAIN (Other)

Control

Active Comparator

Control arm participants will be offered different videos or podcast episodes that are unrelated to the study topics of infections, substance use, overdose, and medication management.

干预措施: Unrelated videos (Other)

结局指标

主要结局

Participant recruitment rates

时间窗: Baseline while hospitalized, then 2 weeks, 6 weeks, 3 months, and 6 months after discharge

Participant recruitment rates will be calculated by dividing the number of participants enrolled by the number of eligible patients identified.

Feasibility of the RETAIN Intervention based on completion of study visits

时间窗: Baseline while hospitalized, then 2 weeks, 6 weeks, 3 months, and 6 months after discharge

The rates of completion of study visits will be calculated by dividing the number of completed study visits by the total number of study visits.

Acceptability of the RETAIN Intervention

时间窗: Baseline while hospitalized, then 2 weeks, 6 weeks, 3 months, and 6 months after discharge

Acceptability will be assessed using the Acceptability of Intervention Measure (AIM) which is a 4-item measure of perceived intervention acceptability. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean and higher scores are associated with better acceptability.

Number of days on medications for opioid disorder (MOUD)

时间窗: Baseline while hospitalized, then 2 weeks, 6 weeks, 3 months, and 6 months after discharge

The timeline follow back (TLFB) method will be used to assess this outcome based on self-report.

次要结局

  • Number of days of antibiotic completion(Baseline while hospitalized, then 2 weeks, 6 weeks, 3 months, and 6 months after discharge)
  • Number of days of Opioid use(Baseline while hospitalized, then 2 weeks, 6 weeks, 3 months, and 6 months after discharge)
  • Number of Hospitalizations(Baseline while hospitalized, then 2 weeks, 6 weeks, 3 months, and 6 months after discharge)
  • Number of uncleaned injections(Baseline while hospitalized, then 2 weeks, 6 weeks, 3 months, and 6 months after discharge)
  • Number of unmonitored opioid use(Baseline while hospitalized, then 2 weeks, 6 weeks, 3 months, and 6 months after discharge)
  • MOUD stigma(Baseline while hospitalized, and 6 month after discharge)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验